Saturday, April 23, 2016



Cancer facts

Cancer is the uncontrolled growth of abnormal cells anywhere in a body.
There are over 200 types of cancer.
Anything that may cause a normal body cell to develop abnormally potentially can cause cancer; general categories of cancer-related or causative agents are as follows: chemical or toxic compound exposures, ionizing radiation, some pathogens, and human genetics.
Cancer symptoms and signs depend on the specific type and grade of cancer; although general signs and symptoms are not very specific the following can be found in patients with different cancers: fatigue, weight loss, pain, skin changes, change in bowel or bladder function, unusual bleeding, persistent cough or voice change, fever, lumps, or tissue masses.
Although there are many tests to screen and presumptively diagnose cancer, the definite diagnosis is made by examination of a biopsy sample of suspected cancer tissue.
Cancer staging is often determined by biopsy results and helps determine the cancer type and the extent of cancer spread; staging also helps caregivers determine treatment protocols. In general, in most staging methods, the higher the number assigned (usually between 0 to 4), the more aggressive the cancer type or more widespread is the cancer in the body.
Treatment protocols vary according to the type and stage of the cancer. Most treatment protocols are designed to fit the individual patient's disease. However, most treatments include at least one of the following and may include all: surgery, chemotherapy, and radiation therapy.
There are many listed home remedies and alternative treatments for cancers but patients are strongly recommended to discuss these before use with their cancer doctors.
The prognosis of cancer can range from excellent to poor. The prognosis depends on the cancer type and its staging with those cancers known to be aggressive and those staged with higher numbers (3 to 4) often have a prognosis that ranges more toward poor



What is cancer?

 Readers Comments 26  Share Your Story
Cancer is the uncontrolled growth of abnormal cells anywhere in a body. These abnormal cells are termed cancer cells, malignant cells, or tumor cells. These cells can infiltrate normal body tissues. Many cancers and the abnormal cells that compose the cancer tissue are further identified by the name of the tissue that the abnormal cells originated from (for example, breast cancer, lung cancer, colon cancer). Cancer is not confined to humans; animals and other living organisms can get cancer. Below is a schematic that shows normal cell division and how when a cell is damaged or altered without repair to its system, the cell usually dies. Also shown is what occurs when such damaged or unrepaired cells do not die and become cancer cells and show uncontrolled division and growth -- a mass of cancer cells develop. Frequently, cancer cells can break away from this original mass of cells, travel through the blood and lymph systems, and lodge in other organs where they can again repeat the uncontrolled growth cycle. This process of cancer cells leaving an area and growing in another body area is termed metastatic spread or metastasis. For example, if breast cancer cells spread to a bone, it means that the individual has metastatic breast cancer to bone. This is not the same as "bone cancer," which would

There are over 200 types of cancers; most can fit into the following categories according to the National Cancer Institute:

Carcinoma: Cancer that begins in the skin or in tissues that line or cover internal organs
Sarcoma: Cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue
Leukemia: Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of abnormal blood cells to be produced and enter the blood
Lymphoma and myeloma: Cancers that begin in the cells of the immune system
Central nervous system cancers: Cancers that begin in the tissues of the brain and spinal cord
The following table (National Cancer Institute 2015) gives the estimated numbers of new cases and deaths for each common cancer type:

The three most common cancers in men, women, and children in the U.S. are as follows:

Men: Prostate, lung, and colorectal
Women: Breast, lung, and colorectal
Children: Leukemia, brain tumors, and lymphoma
The incidence of cancer and cancer types are influenced by many factors such as age, gender, race, local environmental factors, diet, and genetics. Consequently, the incidence of cancer and cancer types vary depending on these variable factors. For example, the World Health Organization (WHO) provides the following general information about cancer worldwide:

Cancer is a leading cause of death worldwide. It accounted for 8.2 million deaths (around 22% of all deaths not related to communicable diseases; most recent data from WHO).
Lung, stomach, liver, colon, and breast cancer cause the most cancer deaths each year.
Deaths from cancer worldwide are projected to continue rising, with an estimated 13.1 million deaths in 2030 (about a 70% increase).
Different areas of the world may have cancers that are either more or less predominant then those found in the U.S. One example is that stomach cancer is often found in Japan, while it is rarely found in the U.S. This usually represents a combination of environmental and genetic factors.

The objective of this article is to introduce the reader to general aspects of cancers. It is designed to be an overview of cancer and cannot cover every cancer type. This article will also attempt to help guide the reader to more detailed sources about specific cancer types

What causes cancer?

Anything that may cause a normal body cell to develop abnormally potentially can cause cancer. Many things can cause cell abnormalities and have been linked to cancer development. Some cancer causes remain unknown while other cancers have environmental or lifestyle triggers or may develop from more than one known cause. Some may be developmentally influenced by a person's genetic makeup. Many patients develop cancer due to a combination of these factors. Although it is often difficult or impossible to determine the initiating event(s) that cause a cancer to develop in a specific person, research has provided clinicians with a number of likely causes that alone or in concert with other causes, are the likely candidates for initiating cancer. The following is a listing of major causes and is not all-inclusive as specific causes are routinely added as research advances:

Chemical or toxic compound exposures: Benzene, asbestos, nickel, cadmium, vinyl chloride, benzidine, N-nitrosamines, tobacco or cigarette smoke (contains at least 66 known potential carcinogenic chemicals and toxins), and aflatoxin

Ionizing radiation: Uranium, radon, ultraviolet rays from sunlight, radiation from alpha, beta, gamma, and X-ray-emitting sources


Pathogens: Human papillomavirus (HPV), EBV or Epstein-Barr virus, hepatitis viruses B and C, Kaposi's sarcoma-associated herpes virus (KSHV), Merkel cell polyomavirus, Schistosoma spp., and Helicobacter pylori; other bacteria are being researched as possible agents.

Genetics: A number of specific cancers have been linked to human genes and are as follows: breast, ovarian, colorectal, prostate, skin and melanoma; the specific genes and other details are beyond the scope of this general article so the reader is referred to the National Cancer Institute for more details about genetics and cancer.

It is important to point out that most everyone has risk factors for cancer and is exposed to cancer-causing substances (for example, sunlight, cigarette smoke, and X-rays) during their lifetime, but many individuals do not develop cancer. In addition, many people have the genes that are linked to cancer but do not develop it. Why? Although researchers may not be able give a satisfactory answer for every individual, it is clear that the higher the amount or level of cancer-causing materials a person is exposed to, the higher the chance the person will develop cancer. In addition, the people with genetic links to cancer may not develop it for similar reasons (lack of enough stimulus to make the genes function). In addition, some people may have a heightened immune response that controls or eliminates cells that are or potentially may become cancer cells. There is evidence that even certain dietary lifestyles may play a significant role in conjunction with the immune system to allow or prevent cancer cell survival. For these reasons, it is difficult to assign a specific cause of cancer to many individuals.

Recently, other risk factors have been added to the list of items that may increase cancer risk. Specifically, red meat (such as beef, lamb, and pork )was classified by the International Agency for Research on Cancer as a high-risk agent for potentially causing cancers; in addition processed meats (salted, smoked, preserved, and/or cured meats) were placed on the carcinogenic list. Individuals that eat a lot of barbecued meat may also increase risk due to compounds formed at high temperatures. Other less defined situations that may increase the risk of certain cancers include obesity, lack of exercise, chronic inflammation, and hormones, especially those hormones used for replacement therapy. Other items such as cell phones have been heavily studied. In 2011, the World Health Organization classified cell phone low energy radiation as "possibly carcinogenic" but this is a very low risk level that puts cell phones at the same risk as caffeine and pickled vegetables.

Proving that a substance does not cause or is not related to increased cancer risk is difficult. For example, antiperspirants are considered to possibly be related to breast cancer by some investigators and not by others. The official stance by the NCI is "additional research is needed to investigate this relationship and other factors that may be involved." This unsatisfying conclusion is presented because the data collected so far is contradictory. Other claims that are similar require intense and expensive research that may never be done. Reasonable advice might be to avoid large amounts of any compounds even remotely linked to cancer, although it may be difficult to do in complex, technologically advanced modern societies

What are cancer symptoms and signs?

Read Doctor's View  Readers Comments 8  Share Your Story
Symptoms and signs of cancer depend on the type of cancer, where it is located, and/or where the cancer cells have spread. For example, breast cancer may present as a lump in the breast or as nipple discharge while metastatic breast cancer may present with symptoms of pain (if spread to bones), extreme fatigue (lungs), or seizures (brain). A few patients show no signs or symptoms until the cancer is far advanced.

The American Cancer Society describes seven warning signs that a cancer may be present, and which should prompt a person to seek medical attention. The word CAUTION can help you remember these.

Change in bowel or bladder habits
A sore throat that does not heal
Unusual bleeding or discharge (for example, nipple secretions or a "sore" that will not heal that oozes material)

Thickening or lump in the breast, testicles, or elsewhere
Indigestion (usually chronic) or difficulty swallowing
Obvious change in the size, color, shape, or thickness of a wart or mole
Nagging cough or hoarseness
Other signs or symptoms may also alert you or your doctor to the possibility of your having some form of cancer. These include the following:

Unexplained loss of weight or loss of appetite
A new type of pain in the bones or other parts of the body that may be steadily worsening, or come and go, but is unlike previous pains one has had before
Persistent fatigue, nausea, or vomiting
Unexplained low-grade fevers with may be either persistent or come and go
Recurring infections which will not clear with usual treatment
Anyone with these signs and symptoms should consult their doctor; these symptoms may also arise from noncancerous conditions.

Many cancers will present with some of the above general symptoms but often have one or more symptoms that are more specific for the cancer type. For example, lung cancer may present with common symptoms of pain, but usually the pain is located in the chest. The patient may have unusual bleeding, but the bleeding usually occurs when the patient coughs. Lung cancer patients often become short of breath and then become very fatigued.

Because there are so many cancer types (see next section) with so many nonspecific and sometimes more specific symptoms, the best way to learn about signs and symptoms of specific cancer types is to spend a few moments researching symptoms of a specific body area in question. Conversely, a specific body area can be searched to discover what signs and symptoms a person should look for in that area that is suspected of having cancer. The following examples are two ways to proceed to get information on symptoms:

Use a search engine (Google, Bing) to find links to cancer by listing the symptom followed by the term "cancer" or if you know the type you want information about, (lung, brain, breast) use MedicineNet’s search option. For example, listing "blood in urine and cancer" will bring a person to web sites that list possible organs and body systems where cancer may produce the listed symptoms.
Use a search engine as above and list the suspected body area and cancer (for example, bladder and cancer), and the person will see sites that list the signs and symptoms of cancer in that area (blood in urine being one of several symptoms listed).
Be aware that many web sites are not necessarily reviewed by a health care professional and could contain information that is not accurate. Your health care professional is ultimately the best resource if you have concerns.
In addition, if the cancer type is known (diagnosed), then even more specific searches can be done listing the diagnosed cancer type and whatever may be questioned about the cancer (symptoms, tumor grades, treatments, prognosis, and many other items).

One's own research should not replace consulting a health-care provider if someone is concerned about cancer.

What are the different types of cancer?

There are over 200 types of cancer; far too numerous to include in this introductory article. However, the NCI lists several general categories (see list in first section of this article). This list is expanded below to list more specific types of cancers found in each general category; it is not all inclusive and the cancers listed in quotes are the general names of some cancers:

Carcinoma: Cancer that begins in the skin or in tissues that line or cover internal organs -- "skin, lung, colon, pancreatic, ovarian cancers," epithelial, squamous and basal cell carcinomas, melanomas, papillomas, and adenomas
Sarcoma: Cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue -- "bone, soft tissue cancers," osteosarcoma, synovial sarcoma, liposarcoma, angiosarcoma, rhabdosarcoma, and fibrosarcoma
Leukemia: Cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of

abnormal blood cells to be produced and enter the blood -- "leukemia," lymphoblastic leukemias (ALL and CLL), myelogenous leukemias (AML and CML), T-cell leukemia, and hairy-cell leukemia
Lymphoma and myeloma: Cancers that begin in the cells of the immune system -- "lymphoma," T-cell lymphomas, B-cell lymphomas, Hodgkin lymphomas, non-Hodgkin lymphoma, and lymphoproliferative lymphomas
Central nervous system cancers: Cancers that begin in the tissues of the brain and spinal cord -- "brain and spinal cord tumors," gliomas, meningiomas, pituitary adenomas, vestibular schwannomas, primary CNS lymphomas, and primitive neuroectodermal tumors
Not included in the above types listed are metastatic cancers; this is because metastatic cancer cells usually arise from a cell type listed above and the major difference from the above types is that these cells are now present in a tissue from which the cancer cells did not originally develop. Consequently, if the terms "metastatic cancer" is used, for accuracy, the tissue from which the cancer cells arose should be included. For example, a patient may say they have or are diagnosed with "metastatic cancer" but the more accurate statement is "metastatic (breast, lung, colon, or other type) cancer with spread to the organ in which it has been found." Another example is the following: A doctor describing a man whose prostate cancer has spread to his bones should say the man has metastatic prostate cancer to bone. This is not "bone cancer," which would be cancer that started in the bone cells. Metastatic prostate cancer to bone is treated differently than lung cancer to bone


How is cancer diagnosed?

 Readers Comments 1  Share Your Story
Some cancers are diagnosed during routine screening examinations. These are usually tests that are routinely done at a certain age. Many cancers are discovered when you present to your health care professional with specific symptoms.

A physical exam and medical history, especially the history of symptoms, are the first steps in diagnosing cancer. In many instances, the medical caregiver will order a number of tests, most of which will be determined by the type of cancer and where it is suspected to be located in or on the person's body. In addition, most caregivers will order a complete blood count, electrolyte levels and, in some cases, other blood studies that may give additional information.

Imaging studies are commonly used to help physicians detect abnormalities in the body that may be cancer. X-rays, CT and MRI scans, and ultrasound are common tools used to examine the body. Other tests such as endoscopy, which with variations in the equipment used, can allow visualization of tissues in the intestinal tract, throat, and bronchi that may be cancerous. In areas that cannot be well visualized (inside bones or some lymph nodes, for example), radionuclide

The preceding tests can be very good at localizing abnormalities in the body; many clinicians consider that some of the tests provide presumptive evidence for the diagnosis of cancer. However, in virtually all patients, the definitive diagnosis of cancer is based on the examination of a tissue sample taken in a procedure called a biopsy from the tissue that may be cancerous, and then analyzed by a pathologist. Some biopsy samples are relatively simple to procure (for example, skin biopsy or intestinal tissue biopsy done with a device called an endoscope equipped with a biopsy attachment). Other biopsies may require as little as a carefully guided needle, or as much as a surgery (for example, brain tissue or lymph node biopsy). In some instances, the surgery to diagnose the cancer may result in a cure if all of the cancerous tissue is removed at the time of biopsy.

The biopsy can provide more than the definitive diagnosis of cancer; it can identify the cancer type (for example, the type of tissue found may indicate that the sample is from a primary [started there] or metastatic type of brain cancer [spread from another primary tumor arising elsewhere in the body]) and thereby help to stage the cancer. The stage, or cancer staging, is a way for clinicians and researchers to estimate how extensive the cancer is in the patient's body.

Is the cancer that has been found localized to its site of origin, or is it spread from that site to other tissues? A localized cancer is said to be at an early stage, while one which has spread is at and advanced stage. The following section describes the general staging methods for cancers

How is cancer staging determined?

There are a number of different staging methods used for cancers and the specific staging criteria varies among cancer types. According to the NCI, the common elements considered in most staging systems are as follows:

Site of the primary tumor
Tumor size and number of tumors
Lymph node involvement (spread of cancer into lymph nodes)
Cell type and tumor grade* (how closely the cancer cells resemble normal tissue cells)
The presence or absence of metastasis
However, there are two main methods that form the basis for the more specific or individual cancer type staging. The TMN staging is used for most solid tumors while the Roman numeral or stage grouping method is used by some clinicians and

researchers on almost all cancer types.

The TNM system is based on the extent of the tumor (T), the extent of spread to the lymph nodes (N), and the presence of distant metastasis (M). A number is added to each letter to indicate the size or extent of the primary tumor and the extent of cancer spread (higher number means bigger tumor or more spread).

The following is how the NCI describes the TNM staging system:

Primary tumor (T)
TX - Primary tumor cannot be evaluated
T0 - No evidence of primary tumor
Tis - Carcinoma in situ (CIS; abnormal cells are present but have not spread to neighboring tissue; although not cancer, CIS may become cancer and is sometimes called pre-invasive cancer)
T1, T2, T3, T4 - Size and/or extent of the primary tumor
Regional lymph nodes (N)
NX - Regional lymph nodes cannot be evaluated
N0 - No regional lymph node involvement
N1, N2, N3 - Involvement of regional lymph nodes (number of lymph nodes and/or extent of spread)
Distant metastasis (M)
MX - Distant metastasis cannot be evaluated (some clinicians do not ever use this designation)
M0 - No distant metastasis
M1 - Distant metastasis is present
Consequently, a person's cancer could be listed as T1N2M0, meaning it is a small tumor (T1), but has spread to some regional lymph nodes (N2), and has no distant metastasis (M0).

The Roman numeral or stage grouping method is described by the NCI as follows:

In situ: Abnormal cells are present only in the layer of cells in which they developed.
Localized: Cancer is limited to the organ in which it began, without evidence of spread.
Regional: Cancer has spread beyond the primary site to nearby lymph nodes or organs and tissues.
Distant: Cancer has spread from the primary site to distant organs or distant lymph nodes.
Unknown: There is not enough information to determine the stage.
Staging of cancer is important; it helps the physician to decide on the most effective therapeutic protocols, provides a basis for estimating the prognosis (outcome) for the patient, and provides a system to communicate the patient's condition to other health professionals that become involved with the patients' care

What is the treatment for cancer?

 Readers Comments 1  Share Your Story
A doctor who specialized in the treatment of cancer is called an oncologist. He or she may be a surgeon, a specialist in radiation therapy, or a medical oncologist. The first uses surgery to treat the cancer; the second, radiation therapy; the third, chemotherapy and related treatments. Each may consult with the others to develop a treatment plan for the particular patient.

The treatment is based on the type of cancer and the stage of the cancer. In some people, diagnosis and treatment may occur at the same time if the cancer is entirely surgically removed when the surgeon removes the tissue for biopsy.

Although patients may receive a unique sequenced treatment, or protocol, for their cancer, most treatments have one or more of the following components: surgery, chemotherapy, radiation therapy, or combination treatments (a combination of two or all three treatments).

Individuals obtain variations of these treatments for cancer. Patients with cancers that cannot be cured (completely removed) by surgery usually will get combination therapy, the composition determined by the cancer type and stage.

Palliative therapy (medical care or treatment used to reduce disease symptoms but unable to cure the patient) utilizes the same treatments described above. It is done with the intent to extend and improve the quality of life of the terminally ill cancer patient. There are many other palliative treatments to reduce symptoms such as pain medications and antinausea medications.


Are there home remedies or alternative treatments for cancer?

There are many claims on the internet and in publications about substances that treat cancer (for example, brocolli, grapes, ginseng, soybeans, green tea, aloe vera, and lycopene and treatments like acupuncture, vitamins, and dietary supplements). Although some of these treatments may help reduce symptoms, there is no good evidence they can cure any cancers. Patients are strongly recommended to discuss any home remedies or alternative treatments with their cancer doctors before beginning any of these.


What is the prognosis for cancer?

The prognosis (outcome) for cancer patients may range from excellent to poor. The prognosis is directly related to both the type and stage of the cancer. For example, many skin cancers can be completely cured by removing the skin cancer tissue; similarly, even a patient with a large tumor may be cured after surgery and other treatments like chemotherapy (note that a cure is often defined by many clinicians as a five-year period with no reoccurrence of the cancer). However, as the cancer type either is or becomes aggressive, with spread to lymph nodes or is metastatic to other organs, the prognosis decreases. For example, cancers that have higher numbers in their staging (for example, stage III or T3N2M1; see staging section above) have a worse prognosis than those with low (or 0) numbers. As the staging numbers increase, the prognosis worsens.

This article offers a general introduction to cancers, consequently the details -- such as life expectancy for each cancer -- cannot be covered. However, cancers in general have a decreasing life expectancy as the stage of the cancer increases. Depending on the type of the cancer, as the prognosis decreases, so does life expectancy. On the positive side, cancers that are treated and do not recur within a 5-year period in general suggest that the patient will have a normal life expectancy. Unfortunately, there are no guarantees.

There are many complications that may occur with cancer; many are specific to the cancer type and stage and are too numerous to list here. However, some general complications that may occur with both cancer and its treatment protocols are listed below:

Can cancer be prevented?

 Share Your Story
Most experts are convinced that many cancers can either be prevented or the risk of developing cancers can be markedly reduced. Some of the methods are simple; others are relatively extreme, depending on an individual's view.

Prevention of cancer, by avoiding its potential causes, is the simplest method. First on most clinicians and researchers list is to stop (or better, never start) smoking tobacco. Avoiding excess sunlight (by decreasing exposure or applying sunscreen) and many of the chemicals and toxins is an excellent way to avoid cancers. Avoiding contact with certain viruses and other pathogens also is likely to prevent some cancers. People who have to work close to cancer-causing agents (chemical workers, X-ray technicians, ionizing radiation researchers) should follow all safety precautions and minimize any exposure to such compounds.

There are two vaccines currently approved by the U.S. Food and Drug Administration (FDA) to prevent specific types of cancer. Vaccines against the hepatitis B virus, which is considered a cause of some liver cancers, and vaccines against

responsible for about 70% of cervical cancers. These virus also plays a role in cancers arising in the head and neck, as well as cancers in the anal region, and probably in others. Today, vaccination against HPV is recommended in teenagers and young adults of both sexes. The HPV virus is so common that by the age of 50, half or more people have evidence of being exposed to it. Sipuleucel-T is a new vaccine approved by the FDA to help treat advanced prostate cancer. Although vaccine does not cure prostate cancer, it has been shown to help extend the lifespan of individuals with advanced prostate cancer.

People with a genetic predisposition to develop certain cancers and others with a history of cancers in their genetically linked relatives currently cannot change their genetic makeup. However, some individuals who have a high possibility of developing genetically linked cancer have taken actions to prevent cancer development. For example, some young women who have had many family members develop breast cancer have elected to have their breast tissue removed even if they have no symptoms or signs of cancer development to reduce or eliminate the possibility they will develop breast cancer. Some doctors consider this as an extreme measure to prevent cancer while others do not.

Screening tests and studies for cancer are meant to help detect a cancer at an early stage when the cancer is more likely to be potentially cured with treatment. Such screening studies are breast exams, testicular exams, colon-rectal exams (colonoscopy), mammography, certain blood tests, prostate exams, urine tests and others. People who have any suspicion that they may have cancer should discuss their concerns with their doctor as soon as possible. Screening recommendations have been the subject of numerous conflicting reports in recent years. Screening may not be cost effective for many groups of patients or lead to unnecessary further invasive tests, but individual patients' unique circumstances should always be considered by doctors in making recommendations about ordering or not ordering screening tests.

Sources of Support

Learning that you have kidney cancer can change your life and the lives of those close to you. These changes can be hard to handle. It's normal for you, your family, and your friends to need help coping with the feelings that a diagnosis of cancer can bring.

Concerns about treatments and managing side effects, hospital stays, and medical bills are common. You may also worry about caring for your family, keeping your job, or continuing daily activities.

Here's where you can go for support:

Doctors, nurses, and other members of your health care team can answer questions about treatment, working, or other activities.
Social workers, counselors, or members of the clergy can be helpful if you want to talk about your feelings or concerns. Often, social workers can suggest resources for financial aid, transportation, home care, or emotional

Support groups also can help. In these groups, patients or their family members meet with other patients or their families to share what they have learned about coping with cancer and the effects of treatment. Groups may offer support in person, over the telephone, or on the Internet. You may want to talk with a member of your health care team about finding a support group.
NCI's Cancer Information Service can help you locate programs and services for people with cancer. Call 1-800-4-CANCER (1-800-422-6237). Or chat using LiveHelp, NCI's instant messaging service, at http://www.cancer.gov/livehelp.

Taking Part in Cancer Research

Doctors all over the world are conducting many types of clinical trials (research studies in which people volunteer to take part). Clinical trials are designed to find out whether new treatments are safe and effective.

Even if the people in a trial do not benefit directly from a treatment, they may still make an important contribution by helping doctors learn more about kidney cancer and how to control it. Although clinical trials may pose some risks, doctors do all they can to protect their patients.

Doctors are studying new targeted therapies and drug combinations for kidney cancer. If you're interested in being part of a clinical trial, talk with your doctor.

NCI's Web site includes a section on clinical trials at http://www.cancer.gov/clinicaltrials. It has general information about clinical trials as well as detailed information about specific ongoing studies of kidney cancer.

Cancer

Kidney cancer facts*

*Kidney cancer facts medical author: Charles P. Davis, MD, PhD

The kidneys are two organs in the body that filter the blood and remove waste material and excess water by making urine that is expelled as waste.
Cancer is the growth of malignant (abnormal) cells within the body.
Although the exact cause of kidney cancer is not known, risk factors include smoking, obesity, high blood pressure, long-term dialysis, Von Hippel-Lindau (VHL) syndrome, occupational exposure (coke oven workers and asbestos workers, for example) and men are at higher risk.
Symptoms of kidney cancer include blood in the urine, pain in the side or flank that is constant, a lump or mass in the abdomen or side, fever, weight loss, and fatigue.
The following tests are used to help diagnose kidney cancer: physical exam, urine tests, blood tests, intravenous pyelogram, CT scan, MRI scan, ultrasound, biopsy of kidney tissue, and surgical removal of kidney tissue.
Kidney cancer is staged by measuring the size of the tumor, the location of the cancer cells either confined to the kidney, locally spread or widespread beyond the fibrous tissue surrounding the kidney (stages I through IV).
Treatment of kidney cancer includes one of or a combination of the following methods: chemotherapy, radiation therapy, embolization, biological therapy, and surgery
Side effects of kidney cancer treatment related to the methods used and may include nausea and vomiting, weakness, weight loss, infection, flu-like symptoms, diarrhea, skin rash and hair loss.
After treatment, follow-up care is very important to monitor recovery and to check for any possible recurrence of kidney cancer.
Research is ongoing; combined chemotherapy and stem cell transplantation is an active area of research. Other studies include developing cancer vaccines to help the immune system attack \

What are the kidneys?

Your kidneys are a pair of organs in your abdomen. Each kidney is about the size of a fist.

Your kidneys are part of the urinary tract. They make urine by removing wastes and extra water from your blood.

Urine collects in a hollow space (renal pelvis) in the middle of each kidney. Urine passes from your renal pelvis into your bladder through a long tube called a ureter. Urine leaves your bladder through a shorter tube (the urethra).

Your kidneys also make substances to help control blood pressure and to make red blood cells.

Attached to the top of each kidney is an adrenal gland. A layer of fatty tissue and an outer layer of fibrous tissue surround the kidney and adrenal gland.


What is cancer?

Cancer begins in cells, the building blocks that make up tissues. Tissues make up the kidneys and the other organs of the

Normal cells grow and divide to form new cells as the body needs them. When normal cells grow old or get damaged, they die, and new cells take their place.

Sometimes, this process goes wrong. New cells form when the body doesn't need them, and old or damaged cells don't die as they should. The buildup of extra cells often forms a mass of tissue called a growth or tumor.

Tumors in the kidney can be benign (not cancer) or malignant (cancer). Benign tumors are not as harmful as malignant tumors:

Benign tumors (such as cysts):
are usually not a threat to life
can be treated or removed and usually don't grow back
don't invade the tissues around them
don't spread to other parts of the body
Malignant growths:
may be a threat to life
usually can be removed but can grow back
can invade and damage nearby tissues and organs
can spread to other parts of the body
Kidney cancer cells can spread by breaking away from the kidney tumor. They can travel through lymph vessels to nearby lymph nodes. They can also spread through blood vessels to the lungs, bones, or liver. After spreading, kidney cancer cells may attach to other tissues and grow to form new tumors that may damage those tissues

What are kidney cancer causes and risk factors?

 Share Your Story
When you get a diagnosis of kidney cancer, it's natural to wonder what may have caused the disease. Doctors usually can't explain why one person gets kidney cancer and another doesn't.

However, we do know that people with certain risk factors may be more likely than others to develop kidney cancer. A risk factor is something that may increase the chance of getting a disease.

Studies have found the following risk factors for kidney cancer:

Smoking: Smoking tobacco is an important risk factor for kidney cancer. People who smoke have a higher risk than nonsmokers. The risk is higher for those who smoke more cigarettes or for a long time.
Obesity: Being obese increases the risk of kidney cancer.

High blood pressure: Having high blood pressure may increase the risk of kidney cancer.
Family history of kidney cancer: People with a family member who had kidney cancer have a slightly increased risk of the disease. Also, certain conditions that run in families can increase the risk of kidney cancer.
Von Hippel-Lindau (VHL) syndrome: VHL is a rare disease that runs in some families. It's caused by changes in the VHL gene. People with a changed VHL gene have an increased risk of kidney cancer. They may also have cysts or tumors in the eyes, brain, or other parts of the body. Family members of those with VHL can have a test to check for a changed VHL gene.
Many people who get kidney cancer have none of these risk factors, and many people who have known risk factors don't develop the disease

What are kidney cancer symptoms and signs?

 Readers Comments 50  Share Your Story
Common symptoms of kidney cancer include:

Blood in the urine (making the urine slightly rusty to deep red)
Pain in your side that doesn't go away
A lump or mass in the side or the abdomen
Weight loss for no known reason
Fever
Feeling very tired

How is kidney cancer diagnosed?

 Readers Comments 7  Share Your Story
If you have symptoms that suggest kidney cancer, your doctor will try to find out what's causing the problems.

You may have a physical exam. Also, you may have one or more of the following tests:

Urine tests: The lab checks your urine for blood and other signs of disease.
Blood tests: The lab checks your blood for several substances, such as creatinine. A high level of creatinine may mean the kidneys aren't doing their job.
Ultrasound: An ultrasound device uses sound waves that can't be heard by humans. The sound waves make a pattern of echoes as they bounce off organs inside your abdomen. The echoes create a picture of your kidney and nearby tissues. The picture can show a kidney tumor.

CT scan: An x-ray machine linked to a computer takes a series of detailed pictures of your abdomen. You may receive an injection of contrast material so your urinary tract and lymph nodes show up clearly in the pictures. The CT scan can show cancer in the kidneys, lymph nodes, or elsewhere in the abdomen.
MRI: A large machine with a strong magnet linked to a computer is used to make detailed pictures of your urinary tract and lymph nodes. You may receive an injection of contrast material. MRI can show cancer in your kidneys, lymph nodes, or other tissues in the abdomen.
IVP: You'll receive an injection of dye into a vein in your arm. The dye travels through the body and collects in your kidneys. The dye makes them show up on x-rays. A series of x-rays then tracks the dye as it moves through your kidneys to your ureters and bladder. The x-rays can show a kidney tumor or other problems. (IVP is not used as commonly as CT or MRI for the detection of kidney cancer.)
Biopsy: The removal of tissue to look for cancer cells is a biopsy. In some cases, your doctor will do a biopsy to diagnose kidney cancer. Your doctor inserts a thin needle through your skin into the kidney to remove a small sample of tissue. Your doctor may use ultrasound or a CT scan to guide the needle. A pathologist uses a microscope to check for cancer cells in the tissue.
Surgery: After surgery to remove part or all of a kidney tumor, a pathologist can make the final diagnosis by checking the tissue under a microscope for cancer cells.

How is kidney cancer staging determined?

 Readers Comments 9  Share Your Story
Staging

If kidney cancer is diagnosed, your doctor needs to learn the extent (stage) of the disease to help you choose the best treatment. The stage is based on the size of the kidney tumor and whether the cancer has invaded nearby tissues or spread to other parts of the body.

Your doctor may order one or more tests:

Blood tests: Your doctor can check for substances in your blood. Some people with kidney cancer have high levels of calcium or LDH. A blood test can also show how well your liver is working.
Chest x-ray: An x-ray of the chest can show a tumor in your lung.

CT scan: CT scans of your chest and abdomen can show cancer in your lymph nodes, lungs, or elsewhere.
MRI: MRI can show cancer in your blood vessels, lymph nodes, or other tissues in the abdomen.
When cancer spreads from its original place to another part of the body, the new tumor has the same kind of abnormal cells and the same name as the primary (original) tumor. For example, if kidney cancer spreads to a lung, the cancer cells in the lung are actually kidney cancer cells. The disease is metastatic kidney cancer, not lung cancer. It's treated as kidney cancer, not as lung cancer. Doctors sometimes call the new tumor “distant” disease.

These are the stages of kidney cancer:

Stage I: The tumor is no bigger than a tennis ball (almost 3 inches or about 7 centimeters). Cancer cells are found only in the kidney.
Stage II: The tumor is bigger than a tennis ball. But cancer cells are found only in the kidney.
Stage III: The tumor can be any size. It has spread to at least one nearby lymph node. Or it has grown through the kidney to reach nearby blood vessels.
Stage IV: The tumor has grown through the layer of fatty tissue and the outer layer of fibrous tissue that surrounds the kidney. Or cancer cells have spread to nearby lymph nodes or to the lungs, liver, bones, or other tissues.
Treatment

Common treatment options for people with kidney cancer are surgery, targeted therapy, and biological therapy. You may receive more than one type of treatment.

The treatment that's right for you depends mainly on the following:

The size of the tumor
Whether the tumor has invaded tissues outside the kidney
Whether the tumor has spread to other parts of the body
Your age and general health
You may have a team of specialists to help plan your treatment. Your doctor may refer you to a specialist, or you may ask for a referral.

You may want to see a urologist, a surgeon who specializes in treating problems of the urinary tract. Other specialists who treat kidney cancer include urologic oncologists (surgeons who specialize in cancers of the urinary tract), medical oncologists, and radiation oncologists. Your health care team may also include an oncology nurse and a registered dietitian.

Your health care team can describe your treatment choices, the expected results of each, and the possible side effects. Because cancer therapy often damages healthy cells and tissues, side effects are common. Before treatment starts, ask your health care team about possible side effects and how treatment may change your normal activities. You and your health care team can work together to develop a treatment plan that meets your needs.

At any stage of disease, supportive care is available to control pain and other symptoms, to relieve the side effects of treatment, and to ease emotional concerns. Information about such care is available on NCI's Web site at http://www.cancer.gov/cancertopics/coping. For example, some people with kidney cancer may need to have radiation therapy to relieve pain or certain other problems. Radiation therapy uses highenergy rays to kill cancer cells.

Also, NCI's Cancer Information Service can answer your questions about supportive care. Call 1-800-4-CANCER (1-800-422-6237). Or chat using LiveHelp, NCI's instant messaging service, at http://www.cancer.gov/livehelp.

You may want to talk with your doctor about taking part in a clinical trial. Clinical trials are research studies testing new treatments. They are an important option for people with all stages of kidney cancer.

You may want to ask your doctor these questions before you begin treatment:

How large is the tumor? What is the stage of the disease? Has the tumor grown outside the kidney or spread to other organs?
What are my treatment choices? Which do you suggest for me? Why?
What are the expected benefits of each kind of treatment?
What can I do to prepare for treatment?
Will I need to stay in the hospital? If so, for how long?
What are the risks and possible side effects of each treatment? How can side effects be managed?
What is the treatment likely to cost? Will my insurance cover it?
How will treatment affect my normal activities?
Would a research study (clinical trial) be a good choice for me?
Can you recommend a doctor who could give me a second opinion about my treatment options?
How often should I have checkups?

What are kidney cancer treatments?

Surgery

Surgery is the most common treatment for people with kidney cancer. The type of surgery depends on the size and stage of the cancer, whether you have two kidneys, and whether cancer was found in both kidneys.

You and your surgeon can talk about the types of surgery and which may be right for you:

Removing all of the kidney (radical nephrectomy): The surgeon removes the entire kidney along with the adrenal gland and some tissue around the kidney. Some lymph nodes in the area may also be removed.
Removing part of the kidney (partial nephrectomy): The surgeon removes only the part of the kidney that contains the tumor. People with a kidney tumor that is smaller than a tennis ball may choose this type of surgery.
There are two approaches for removing the kidney. The surgeon may remove the tumor by making a large incision into your

The surgeon sees inside your abdomen with a thin, lighted tube (a laparoscope) placed inside a small incision. Sometimes a robot is used. The surgeon uses handles below a computer display to control the robot's arms.

The surgeon may use other methods of destroying the cancer in the kidney. For people who have a tumor smaller than 4 centimeters and who can't have surgery to remove part of the kidney because of other health problems, the surgeon may suggest:

Cryosurgery: The surgeon inserts a tool through a small incision or directly through the skin into the tumor. The tool freezes and kills the kidney tumor.
Radiofrequency ablation: The surgeon inserts a special probe directly through the skin or through a small incision into the tumor. The probe contains tiny electrodes that kill the kidney cancer cells with heat.
It takes time to heal after surgery, and the time needed to recover is different for each person. It's common to feel weak or tired for a while.

Also, you may have pain or discomfort for the first few days. Medicine can help control your pain. Before surgery, you should discuss the plan for pain relief with your doctor or nurse. After surgery, your doctor can adjust the plan if you need more pain control.

Your health care team will watch you for signs of bleeding, infection, or other problems. They will keep track of how much fluid you take in and how much urine passes out of your body.

If one kidney is removed, the remaining kidney is usually able to do the work of both kidneys. However, if your remaining kidney isn't doing a good job cleaning your blood, you may need dialysis. Some people may need a transplant with a healthy kidney from a donor.

You may want to ask your doctor these questions before having surgery:

What type of surgery do you suggest for me? Do you recommend surgery that is through a large incision? Or through small incisions with a laparoscope? Do you recommend surgery with a robot?
Will lymph nodes and other tissues be removed? Why?
How will I feel after surgery? If I have pain, how can it be controlled?
How long will I be in the hospital?
When will I be able to return to normal activities?
What are the long-term effects of the surgery? Will I need dialysis?

Targeted Therapy

People with kidney cancer that has spread may receive a type of drug called targeted therapy. Many kinds of targeted therapy are used for kidney cancer. This treatment may shrink a kidney tumor or slow its growth.

Usually, the targeted therapy is taken by mouth. You may feel very tired while taking targeted therapy for kidney cancer. Other side effects may include diarrhea, nausea, vomiting, sores on the lips or in the mouth, and high blood pressure.


Biological Therapy

People with kidney cancer that has spread may receive biological therapy. Biological therapy for kidney cancer is a treatment that may improve the body's natural defense (the immune system response) against cancer. The treatments used for kidney cancer can slow the growth of tumors or shrink them. The biological therapy is injected intravenously or under the skin. The treatment may be given at the hospital or a doctor's office.

Other drugs may be given at the same time to prevent side effects. The side effects differ with the biological therapy used,

during treatment. The treatment may also cause a headache, muscle aches, a fever, or weakness.

You may want to ask your doctor these questions about targeted therapy or biological therapy:

Why do I need this treatment?
Which drug or drugs will I receive?
How do the drugs work?
When will treatment start? When will it end?
How will I feel during treatment? What are the side effects? Are there any lasting side effects? What can I do about them?

Before starting treatment, you may want a second opinion about your diagnosis, stage of cancer, and treatment plan. Some people worry that the doctor will be offended if they ask for a second opinion. Usually the opposite is true. Most doctors welcome a second opinion. And many health insurance companies will pay for a second opinion if you or your doctor requests it. Some companies require a second opinion.

If you get a second opinion, the second doctor may agree with your first doctor's diagnosis and treatment plan. Or the second doctor may suggest another approach. Either way, you have more information and perhaps a greater sense of control. You can feel more confident about the decisions you make, knowing that you've looked at all of your options.

It may take some time and effort to gather your medical records and see another doctor. In most cases, it's not a problem to take several weeks to get a second opinion. The delay in starting treatment usually will not make treatment less effective. To make sure, you should discuss this delay with your doctor.

There are many ways to find a doctor for a second opinion. You can ask your doctor, a local or state medical society, a nearby hospital, or a medical school for names of specialists.

Also, you can get information about treatment centers near you from NCI's Cancer Information Service. Call 1-800-4-CANCER (1-800-422-6237). Or chat using LiveHelp, NCI's instant messaging service, at http://www.cancer.gov/livehelp.


Nutrition

It's important for you to take very good care of yourself before, during, and after cancer treatment. Taking care of yourself includes eating well so that you get the right amount of calories to maintain a good weight. You also need enough protein to keep up your strength. Eating well may help you feel better and have more energy.

Sometimes, especially during or soon after treatment, you may not feel like eating. You may be uncomfortable or tired. You may find that foods don't taste as good as they used to. In addition, the side effects of some treatments (such as poor appetite, nausea, or vomiting) can make it hard to eat well.

Your doctor, a registered dietitian, or another health care provider can suggest ways to help you meet your nutrition needs.


Follow-up Care

 Readers Comments 1  Share Your Story
You'll need regular checkups (such as every 6 months) after treatment for kidney cancer. Checkups help ensure that any changes in your health are noted and treated if needed.

Kidney cancer may come back after treatment. Your doctor will check for return of cancer. Checkups may include blood tests, a chest x-ray, CT scans, or an ultrasound

Sources of Support

Learning that you have kidney cancer can change your life and the lives of those close to you. These changes can be hard to handle. It's normal for you, your family, and your friends to need help coping with the feelings that a diagnosis of cancer can bring.

Concerns about treatments and managing side effects, hospital stays, and medical bills are common. You may also worry about caring for your family, keeping your job, or continuing daily activities.

Here's where you can go for support:

Doctors, nurses, and other members of your health care team can answer questions about treatment, working, or other activities.
Social workers, counselors, or members of the clergy can be helpful if you want to talk about your feelings or concerns. Often, social workers can suggest resources for financial aid, transportation, home care, or emotional

Kidney Cancer

Hydronephrosis facts

Hydronephrosis describes swelling of the kidney resulting from the inability of urine to drain from the kidney into the bladder.
Hydroureter describes swelling of the ureter, the tube that connects the kidney to the bladder.
The obstruction may occur at any level in the urinary collecting system from the kidney to the ureter to the bladder to the urethra.
Depending on the level of the cause, hydronephrosis may be unilateral involving one kidney or bilateral involving both.
The increased pressure caused by hydronephrosis potentially can compromise kidney function if it is not relieved in a reasonable period of time.
Symptoms of hydronephrosis depend upon whether the swelling occurs acutely or progresses more gradually. If it is an acute obstruction, symptoms may include writhing pain, nausea, and vomiting.
Treatment of hydronephrosis and hydroureter is aimed at restoring urine flow from the affected kidney.

What is hydronephrosis?

Hydronephrosis describes the situation where the urine collecting system of the kidney is dilated. This may be a normal variant or it may be due to an underlying illness or medical condition.

Normally, the kidney filters waste products from blood and disposes of it in the urine. The urine drains into individual calyces (single=calyx) that form the renal pelvis. This empties into the ureter, a tube that connects the kidney to the bladder. The urethra is the tube that empties the bladder.

While obstruction or blockage is the most frequent cause of hydronephrosis, it may be due to problems that occur congenitally in a fetus (prenatal) or may be a physiologic response to pregnancy. A large percentage of pregnant women develop hydronephrosis or hydroureter. Experts think this is, in part, because of the effects of progesterone on the ureters, which decreases their tone.

Technically, hydronephrosis specifically describes dilation and swelling of the kidney, while the term hydroureter is used to describe swelling of the ureter. Hydronephrosis may be unilateral involving just one kidney or bilateral involving both.

A complication of hydronephrosis that is not physiologic is decreased kidney function. The increased pressure of extra fluid within the kidney decreases the blood filtration rate and may cause structural damage to kidney cells. This decrease in function is often reversible if the underlying condition is corrected but if the duration is prolonged, the damage is often permanent.

What causes hydronephrosis?

 Readers Comments 7  Share Your Story
There are numerous causes of hydronephrosis that are categorized based upon the location of the swelling and whether the cause is intrinsic (located within the urinary collecting system), extrinsic (outside of the collecting system) or if it due to an alteration in function.

Examples of intrinsic causes of hydronephrosis

Ureter

Kidney stone. Likely the most common reason to have unilateral hydronephrosis is a kidney stone that causes obstruction of the ureter. The stone gradually moves from the kidney into the bladder but if it should act like a dam while in the ureter, urine will back up and cause the kidney to swell. This would be classified as an intrinsic obstruction.
Blood clot
Stricture or scarring
Bladder

Bladder cancer
Bladder stones
Cystocele
Bladder neck contracture
Urethra

The inability to empty the bladder (urinary retention) for any reason may cause bilateral hydronephrosis.
Urethral stricture
Urethral valves
Examples of extrinsic causes of hydronephrosis

Ureter

Tumors or cancers that compress the ureter and prevent urine flow. Examples include lymphoma and sarcoma, especially if they are located in the retroperitoneum, where the kidneys and ureters are located behind the sac that contains the bowel.
Retroperitoneal fibrosis
Ovarian vein syndrome
Cancer of the cervix
Cancer of the prostate
Pregnancy
Uterine prolapse
Scarring due to radiation therapy
Urethra

Prostate hypertrophy or swelling is a common cause of urinary retention and subsequent hydronephrosis in males.
Prostate cancer
Examples of functional causes of hydronephrosis

Bladder

Neurogenic bladder or the inability of the bladder to function properly occurs because of damage to the nerves that supply it. This may occur in brain tumors, spinal cord injuries or tumors, multiple sclerosis, and diabetes among other causes.
Vesicoureteral reflux where urine flows backwards from the bladder into the ureter. Prenatal hydronephrosis is an example, though it may occur at any time in life.

What are the symptoms of hydronephrosis?

 Readers Comments 3  Share Your Story
There may or may not be direct symptoms of hydronephrosis depending upon the underlying cause.

Individuals with acute hydronephrosis, for example symptoms from renal colic due to a kidney stone begin with an acute onset of intense flank or back pain radiating to the groin, associated with nausea, vomiting, and sweating. Colicky pain comes and goes and its intensity may cause the person to writhe or roll around or pace in pain. There may be blood seen in the urine.

Chronic hydronephrosis develops over time and there may be no specific symptoms. Tumors in the pelvis or bladder obstruction may develop silently and the person may have symptoms of kidney failure. These are often nonspecific and may include weakness, malaise, chest pain, shortness of breath, leg swelling, nausea and vomiting. If electrolyte abnormalities occur because the kidneys are unable to regulate sodium, potassium, and calcium, there may be heart rhythm disturbances and muscle spasms

When should I seek medical care for hydronephrosis?

A person with acute hydronephrosis usually develops significant pain and needs emergent help with pain control.

Blood in the urine is never normal and should not be ignored. Most often in women, it is due to a bladder infection, but other causes include kidney stones, tumors, and occasionally is associated with appendicitis.

Individuals who have the diagnosis of hydronephrosis who develop a fever need to be seen immediately. If a urinary tract infection occurs and there is decreased urine flow, there is the risk of becoming very ill by developing bacteremia (blood stream bacterial infection).

Hydronephrosis is a true emergency in patients with only one kidney and should the person believe that the lone kidney is at risk, urgent medical care should be accessed.


How is hydronephrosis diagnosed?

The diagnosis begins with taking a history of the symptoms that the patient experiences. The health care practitioner will ask questions that will direct whether further tests need to be ordered. Reviewing the patient's past medical history and family history may be helpful.

Depending upon the situation and whether there is acute onset of symptoms, physical examination may reveal tenderness in the flank or where the kidneys are located. The bladder may be found to be distended when the abdomen is examined. Usually, in males, a rectal examination is done to assess the size of the prostate. In women a pelvic examination may be performed to evaluate the uterus and ovaries.

Laboratory tests

The following laboratory tests may be ordered depending upon what potential diagnosis is being considered.

Urinalysis to look for blood, infection or abnormal cells
Complete blood count (CBC) may reveal anemia or potential infection
Electrolyte analysis may be helpful in chronic hydronephrosis since the kidneys are responsible for maintaining and balancing their concentrations in the blood stream.
BUN (blood urea nitrogen), creatinine and glomerular filtration rate (GFR) are blood tests that help assess kidney function.
Imaging Studies

CT scan of the abdomen can be performed to evaluate the kidney anatomy and make the diagnosis of hydronephrosis. It also may allow the health care practitioner to look for the underlying cause including kidney stones or structures that are compressing the urinary collecting system. Depending upon the situation and the health care practitioner's concerns, the CT may be done with or without contrast dye injected into a vein, and with or without oral contrast (that the patient drinks) to outline the intestine. Most commonly, for kidney stones, neither oral nor intravenous contrast is needed.

Ultrasound is another imaging study that can be done to look for hydronephrosis. The quality of the test depends upon the skill of the ultrasonographer to evaluate the structures in the abdomen and retroperitoneum. Ultrasound is also useful in women who are pregnant where radiation concerns exist.

Intravenous pyelography (IVP) has mostly been replaced by CT scanning but does have a role in diagnosing some patients and its use is now limited.

KUB X-rays (an X-ray that shows the kidney, ureter, and bladder) are used by some urologists to classify a kidney stone as radiodense or radiolucent and may use KUB X-rays to determine if the stone is able to migrate down the ureter into the bladder

What is the treatment for hydronephrosis?

 Readers Comments 12  Share Your Story
The goal of treatment for hydronephrosis is to restart the free flow of urine from the kidney and decrease the swelling and pressure that builds up and decreases kidney function.

The initial care for the patient is aimed at minimizing pain and preventing urinary tract infections. Otherwise, surgical intervention may be required.

The timing of the procedure depends upon the underlying cause of hydronephrosis and hydroureter and the associated medical conditions that may be present. For example, patients with a kidney stone may be allowed 1-2 weeks to pass the stone with only supportive pain control if urine flow is not completely blocked by the stone. If, however, the patient develops an infection or if they only have one kidney, surgical intervention may be done emergently to remove the stone.

Shock wave lithotripsy (SWL or extracorporeal shock wave lithotripsy) is the most common treatment for kidney stones in the U.S.. Shock waves from outside the body are targeted at a kidney stone causing the stone to fragment into tiny pieces that are able to be passed out of the urinary tract in the urine.

For patients with urinary retention and an enlarged bladder as a cause of hydronephrosis, bladder catheterization may be all that is needed for initial treatment. For patients with ureteral strictures or stones that are difficult to remove, a urologist may place a stent into the ureter that bypasses the obstruction and allows urine to flow from the kidney. Using a fiber optic scope inserted through the urethra into the bladder, the urologist can visualize where the ureter enters and can thread the stent through the ureter into the kidney pelvis bypassing any obstruction.

When a stent cannot be placed, an alternative is inserting a percutaneous nephrostomy tube. A urologist or interventional radiologist uses fluoroscopy to insert a tube through the flank directly into the kidney to allow urine to drain.

Some conditions, for example retroperitoneal fibrosis or tumors, may require steroid therapy, a formal operation or laparoscopy to relieve the hydronephrosis or hydroureter while oral alkalinization therapy may be used to dissolve uric acid kidney stones.

What are the complications of hydronephrosis?

 Readers Comments 1  Share Your Story
If hydronephrosis remains untreated, the increased pressure within the kidney may decrease the ability of the kidney to filter blood, remove waste products, and make urine as well as regulate the electrolytes in the body. Hydronephrosis can lead to kidney infections, and in some cases, complete kidney function loss or death. Kidney function will begin decreasing almost immediately with the onset of hydronephrosis but is reversible if the swelling resolves. Usually kidneys recover well even if there is an obstruction lasting up to 6 weeks.

The term acute hydronephrosis may be used when after resolution of the kidney swelling, kidney function returns to normal. Chronic hydronephrosis may be used to describe the situation where kidney function is lost even if the obstruction and swelling have resolved.


Can hydronephrosis be prevented?

Since hydronephrosis is a situation that occurs because of an underlying cause, prevention depends upon avoiding the underlying cause. For example, individuals with kidney stones that cause ureteral obstruction and hydronephrosis may try to decrease the chance of a recurrent stone by keeping well hydrated.

Hydronephrosis


Viral hepatitis facts

 Readers Comments 1  Share Your Story
Many illnesses and conditions can cause inflammation of the liver (hepatitis), but certain viruses cause about half of all hepatitis in people.
Viruses that primarily attack the liver are called hepatitis viruses. There are several types of hepatitis viruses including types A, B, C, D, E, and possibly G. Types A, B, and C are the most common.
All hepatitis viruses can cause acute hepatitis.
Viral hepatitis types B and C can cause chronic hepatitis.
Symptoms of acute viral hepatitis include fatigue, flu-like symptoms, dark urine, light-colored stools, fever, and jaundice; however, acute viral hepatitis may occur with minimal symptoms that go unrecognized. Rarely, acute viral hepatitis causes fulminant hepatic failure.
The symptoms of chronic viral hepatitis often are mild and nonspecific, and the diagnosis of chronic hepatitis often is delayed.
Chronic viral hepatitis often requires treatment in order to prevent progressive liver damage, cirrhosis, liver failure, and liver cancer.
Hepatitis infections can be prevented by avoiding exposure to viruses, and through injectable immunoglobulins or by vaccines; however, vaccines are available for only hepatitis A and B.
Those at risk for viral hepatitis B and C include workers in the health care profession, people with multiple sexual partners, intravenous drug abusers, and people with hemophilia. Blood transfusion is a rare cause of viral hepatitis.

Viral hepatitis definition and overview

Hepatitis means inflammation of the liver. Many illnesses and conditions can cause inflammation of the liver, for example, drugs, alcohol, chemicals, and autoimmune diseases. Many viruses, for example, the virus causing mononucleosis and the cytomegalovirus can inflame the liver. Most viruses, however, do not attack primarily the liver; the liver is just one of several organs that the viruses affect. When most doctors speak of viral hepatitis, they


are using the definition that means hepatitis caused by a few specific viruses that primarily attack the liver and are responsible for about half of all human hepatitis. There are several hepatitis viruses; they have been named types A, B, C, D, E, F (not confirmed), and G. As our knowledge of hepatitis viruses grows, it is likely that this alphabetical list will become longer. The most common hepatitis viruses are types A, B, and C. Reference to the hepatitis viruses often occurs in an abbreviated form (for example, HAV, HBV, HCV represent hepatitis viruses A, B, and C, respectively.) The focus of this article is on these viruses that cause the majority of human viral hepatitis.

Hepatitis viruses replicate (multiply) primarily in the liver cells. This can cause the liver to be unable to perform its functions. The following is a list of major functions of the liver:

The liver helps purify the blood by changing harmful chemicals into harmless ones. The source of these chemicals can be external, such as medications or alcohol, or internal, such as ammonia or bilirubin. Typically, these harmful chemicals are broken down into smaller chemicals or attached to other chemicals that then are eliminated from the body in the urine or stool.
The liver produces many important substances, especially proteins that are necessary for good health. For example, it produces albumin, the protein building block of the body, as well as the proteins that cause blood to clot properly.
The liver stores many sugars, fats and vitamins until they are needed elsewhere in the body.
The liver builds smaller chemicals into larger, more complicated chemicals that are needed elsewhere in the body. Examples of this type of function are the manufacture of a fat, cholesterol, and the protein bilirubin.
When the liver is inflamed, it does not perform these functions well, which brings about many of the symptoms, signs, and problems associated with any type of hepatitis. Each hepatitis viral type (A-F) has both articles and books describing the details of infection with that specific virus. This article is designed to give the reader an overview of the predominant viruses that causes viral hepatitis, their symptoms, diagnosis, and treatments, and should help the reader choose the subject(s) for more in depth information

What are the common types of viral hepatitis?

Although the most common types of viral hepatitis are HAV, HBV and HCV, some clinicians had previously considered the acute and chronic phases of hepatic infections as "types" of viral hepatitis. HAV was considered to be acute viral hepatitis because the HAV infections seldom caused or permanent liver damage that led to hepatic (liver) failure. HBV and HCV produced chronic viral hepatitis. However, these terms are outdated and not currently used as frequently because all of the viruses that cause hepatitis may have acute phase symptoms (see symptoms below). Prevention techniques and vaccinations have markedly reduced the current incidence of common viral hepatitis infections; however, there remains a population of about 800,000 to 1.4 million people in the U.S. with chronic HBV, and about 2.9 to 3.7 million with chronic HCV according to the CDC. Statistics are incomplete for determining how many new infections occur each year; the CDC documented infections but then goes on to estimate the actual numbers by further estimating the number of unreported infections (see following sections and reference 1).

Hepatitis A (HAV)

HAV accounts for an estimated 1,781 new infections per year according to the most recent CDC data. The hepatitis caused

referred to as "infectious hepatitis" because it could be spread easily from person to person like other viral infections. Infection with hepatitis A virus can be spread through the ingestion of food or water, especially where unsanitary conditions allow water or food to become contaminated by human waste containing hepatitis A (the fecal-oral mode of transmission). Hepatitis A typically is spread among household members and close contacts through the passage of oral secretions (intimate kissing) or stool (poor hand washing). It also is common to have infection spread to customers in restaurants and among children and workers in day care centers if hand washing and sanitary precautions are not observed.

Hepatitis B (HBV)

There were an more than 19,000 new cases of HBV infection estimated by the CDC in 2013 and more than 1,800 people die each year due to the consequences of chronic hepatitis B infection in the United States according to the CDC. HBV hepatitis was at one time referred to as "serum hepatitis," because it was thought that the only way HBV could spread was through blood or serum (the liquid portion of blood) containing the virus. It is now known that HBV can spread by sexual contact, the transfer of blood or serum through shared needles in drug abusers, accidental needle sticks with needles contaminated with infected blood, blood transfusions, hemodialysis, and by infected mothers to their newborns. The infection also can be spread by tattooing, body piercing, and sharing razors and toothbrushes (if there is contamination with infected blood). About 6% to 10% of patients with HBV hepatitis develop chronic HBV infection (infection lasting at least six months and often years to decades) and can infect others as long as they remain infected. Patients with chronic HBV infection also are at risk of developing cirrhosis, liver failure, and liver cancer. It is estimated that there are 2.2 million people in the U.S. and 2 billion people world-wide who suffer with chronic HBV infections.

Hepatitis C (HCV)

The CDC reported that there were about 16,500 reported new cases per year (unreported is 13.4 times more than reported) of hepatitis C. HCV hepatitis was previously referred to as "non-A, non-B hepatitis," because the causative virus had not been identified, but it was known to be neither HAV nor HBV. HCV usually is spread by shared needles among drug abusers, blood transfusion, hemodialysis, and needle sticks. Approximately 90% of transfusion-associated hepatitis is caused by HCV. Transmission of the virus by sexual contact has been reported, but is considered rare. An estimated 50% to 70% of patients with acute HCV infection develop chronic infection. Patients with chronic HCV infection can continue to infect others. Patients with chronic HCV infection are at risk for developing cirrhosis, liver failure, and liver cancer. It is estimated that there are about 3.2 million people with chronic HCV infection in the U.S.

Types D, E, and G Hepatitis

There also are viral hepatitis types D, E, and G. The most important of these at present is the hepatitis D virus (HDV), also known as the delta virus or agent. It is a small virus that requires concomitant infection with HBV to survive. HDV cannot survive on its own because it requires a protein that the HBV makes (the envelope protein, also called surface antigen) to enable it to infect liver cells. The ways in which HDV is spread are by shared needles among drug abusers, contaminated blood, and by sexual contact; essentially the same ways as HBV.

Individuals who already have chronic HBV infection can acquire HDV infection at the same time as they acquire the HBV infection, or at a later time. Those with chronic hepatitis due to HBV and HDV develop cirrhosis (severe liver scarring) rapidly. Moreover, the combination of HDV and HBV virus infection is very difficult to treat.

Hepatitis E virus (HEV) is similar to HAV in terms of disease, and mainly occurs in Asia where it is transmitted by contaminated water.

Hepatitis G virus (HGV, also termed GBV-C) was recently discovered and resembles HCV, but more closely, the flaviviruses; the virus and its effects are under investigation, and its role in causing disease in humans is unclear

Who is at risk for viral hepatitis?

People who are most at risk for developing viral hepatitis are:

Workers in the health care professions
Asians and Pacific Islanders
Sewage and water treatment workers
People with multiple sexual partners
Intravenous drug users
HIV patients
People with hemophilia who receive blood clotting factors

Blood transfusion, once a common means of spreading viral hepatitis, now is a rare cause of hepatitis. Viral hepatitis is generally thought to be as much as ten times more common among lower socioeconomic and poorly educated individuals. About one third of all cases of hepatitis come from an unknown or unidentifiable source. This means that a person does not have to be in a high risk group in order to be infected with a hepatitis virus. In countries with poor sanitation, food and water contamination with HAV increases risk. Some day care centers may become contaminated with HAV, so children at such centers are at a higher risk for HAV infections.


What are the symptoms and signs of viral hepatitis?

 Readers Comments 1  Share Your Story
The period of time between exposure to hepatitis and the onset of the illness is called the incubation period. The incubation period varies depending on the specific hepatitis virus. Hepatitis A virus has an incubation period of about 15 to 45 days; Hepatitis B virus from 45 to 160 days, and Hepatitis C virus from about 2 weeks to 6 months.

Many patients infected with HAV, HBV, and HCV have few or no symptoms of illness. For those who do develop symptoms of viral hepatitis, the most common are flu- like symptoms including:

Loss of appetite
Nausea
Vomiting
Fever
Weakness
Tiredness
Aching in the abdomen
Less common symptoms include:

Dark urine
Light-colored stools
Fever

What is acute fulminant hepatitis?

Rarely, individuals with acute infections with HAV and HBV develop severe inflammation, and the liver fails (acute fulminant hepatitis). These patients are extremely ill with the symptoms of acute hepatitis already described and the additional problems of confusion or coma (due to the liver's failure to detoxify chemicals), as well as bruising or bleeding (due to a lack of blood clotting factors). In fact, up to 80% of people with acute fulminant hepatitis can die within days to weeks; therefore, it is fortunate that acute fulminant hepatitis is rare. For example, less than 0.5% of adults with acute infection with HBV will develop acute fulminant hepatitis. This is even less common with HCV alone, although it becomes more frequent when both HBV and HCV are present together.


What is chronic viral hepatitis?

Patients infected with HBV and HCV can develop chronic hepatitis. Doctors define chronic hepatitis as hepatitis that lasts longer than 6 months. In chronic hepatitis, the viruses live and multiply in the liver for years or decades. For unknown reasons, these patients' immune systems are unable to eradicate the viruses, and the viruses cause chronic inflammation of the liver. Chronic hepatitis can lead to the development over time of extensive liver scarring (cirrhosis), liver failure, and liver

How is viral hepatitis diagnosed?

Diagnosis of viral hepatitis is based on symptoms and physical findings as well as blood tests for liver enzymes, viral antibodies, and viral genetic materials.

Symptoms and physical findings

Diagnosis of acute viral hepatitis often is easy, but diagnosis of chronic hepatitis can be difficult. When a patient reports symptoms of fatigue, nausea, abdominal pain, darkening of urine, and then develops jaundice, the diagnosis of acute viral hepatitis is likely and can be confirmed by blood tests. On the other hand, patients with chronic hepatitis due to HBV and HCV often have no symptoms or only mild nonspecific symptoms such as chronic fatigue. Typically, these patients do not have jaundice until the liver damage is far advanced. Therefore, these patients can remain undiagnosed for years to decades.

There are three types of blood tests for evaluating patients with hepatitis: liver enzymes, antibodies to the hepatitis viruses, and viral proteins or genetic material (viral DNA or RNA).

Liver enzymes: Among the most sensitive and widely used blood tests for evaluating patients with hepatitis are the liver enzymes, called aminotransferases. They include aspartate aminotransferase (AST or SGOT) and alanine aminotransferase (ALT or SGPT). These enzymes normally are contained within liver cells. If the liver is injured (as in viral hepatitis), the liver cells spill the enzymes into the blood, raising the enzyme levels in the blood and signaling that the liver is damaged.

The normal range of values for AST is from 5 to 40 units per liter of serum (the liquid part of the blood) while the normal range of values for ALT is from 7 to 56 units per liter of serum. (These normal levels may vary slightly depending on the laboratory.) Patients with acute viral hepatitis (for example, due to HAV or HBV) can develop very high AST and ALT levels, sometimes in the thousands of units per liter. These high AST and ALT levels will become normal in several weeks or months as the patients recover completely from their acute hepatitis. In contrast, patients with chronic HBV and HCV infection typically have only mildly elevated AST and ALT levels, but these abnormalities can last years or decades. Since most patients with chronic hepatitis are asymptomatic (no jaundice or nausea), their mildly abnormal liver enzymes are often unexpectedly encountered on routine blood screening tests during yearly physical examinations or insurance physicals.

Elevated blood levels of AST and ALT only means that the liver is inflamed, and elevations can be caused by many agents other than hepatitis viruses, such as medications, alcohol, bacteria, fungi, etc. In order to prove that a hepatitis virus is responsible for the elevations, blood must be tested for antibodies to each of the hepatitis viruses as well as for their genetic material.

Viral antibodies: Antibodies are proteins produced by white blood cells that attack invaders such as bacteria and viruses. Antibodies against the hepatitis A, B, and C viruses usually can be detected in the blood within weeks of infection, and the antibodies remain detectable in the blood for decades thereafter. Blood tests for the antibodies can be helpful in diagnosing both acute and chronic viral hepatitis.

In acute viral hepatitis, antibodies not only help to eradicate the virus, but they also protect the patient from future infections by the same virus, that is, the patient develops immunity. In chronic hepatitis, however, antibodies and the rest of the immune system are unable to eradicate the virus. The viruses continue to multiply and are released from the liver cells into the blood where their presence can be determined by measuring the viral proteins and genetic material. Therefore in chronic hepatitis, both antibodies to the viruses and viral proteins and genetic material can be detected in the blood.

Examples of tests for viral antibodies are:

anti-HAV (hepatitis A antibody)
antibody to hepatitis B core, an antibody directed against the inner core material of the virus (core antigen)
antibody to hepatitis B surface, an antibody directed against the outer surface envelope of the virus (surface antigen)
antibody to hepatitis B e, an antibody directed against the genetic material of the virus (e antigen)
hepatitis C antibody, the antibody against the C virus
Viral proteins and genetic material: Examples of tests for viral proteins and genetic material are:

hepatitis B surface antigen
hepatitis B DNA
hepatitis B e antigen
hepatitis C RNA
Other tests: Obstruction of the bile ducts, from either gallstones or cancer, occasionally can mimic acute viral hepatitis. Ultrasound testing can be used to exclude the possibility of gallstones or cancer

What is the treatment for viral hepatitis?

 Readers Comments 2  Share Your Story
Treatment of acute viral hepatitis and chronic viral hepatitis are different. Treatment of acute viral hepatitis involves resting, relieving symptoms and maintaining adequate intake of fluids. Treatment of chronic viral hepatitis involves medications to eradicate the virus and taking measures to prevent further liver damage.

Acute hepatitis

In patients with acute viral hepatitis, the initial treatment consists of relieving the symptoms of nausea, vomiting, and abdominal pain (supportive care). Careful attention should be given to medications or compounds, which can have adverse effects in patients with abnormal liver function (for example, acetaminophen [Tylenol and others], alcohol, etc.). Only those medications that are considered necessary should be administered since the impaired liver is not able to eliminate drugs normally, and drugs may accumulate in the blood and reach toxic levels. Moreover, sedatives and "tranquilizers" are avoided because they may accentuate the effects of liver failure on the brain and cause lethargy and

Acute HBV is not treated with antiviral drugs. Acute HCV - though rarely diagnosed - can be treated with several of the drugs used for treating chronic HCV. Treatment of HCV is recommended primarily for the 80% of patients who do not eradicate the virus early. Treatment results in clearing of the virus in the majority of patients.

Chronic hepatitis

Treatment of chronic infection with hepatitis B and hepatitis C usually involves medication or combinations of medications to eradicate the virus. Doctors believe that in properly selected patients, successful eradication of the viruses can stop progressive damage to the liver and prevent the development of cirrhosis, liver failure, and liver cancer. Alcohol aggravates liver damage in chronic hepatitis, and can cause more rapid progression to cirrhosis. Therefore, patients with chronic hepatitis should stop drinking alcohol. Smoking cigarettes also can aggravate liver disease and should be stopped.

Medications for chronic hepatitis C infection include:

injectable alpha interferons (Pegasys)
oral ribavirin (Rebetol, Copegus)
oral boceprevir (Victrelis)
simeprevir (Olysio)
oral sofosbuvir (Sovaldi)
oral simeprevir (Olysio)
oral daclatasvir (Daklinza)
oral ledipasvir/sofosbuvir (Harvoni)
oral ombitasvir/paritaprevir/ritonavir (Technivie)
oral ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak)
Medications for chronic hepatitis B infection include:

injectable alpha interferons
oral lamivudine (Epivir)
oral adefovir (Hepsera)
oral entecavir (Baraclude)
orak telbivudine (Tyzeka)
oral tenofovir (Viread)
Because of constantly ongoing research and development of new antiviral agents, the current list of medications for chronic hepatitis B and C infections is likely to change every year. Many of those drugs which are currently available are rarely used because of newer, safer, and more effective alternatives.

Decisions regarding treatment of chronic hepatitis can be complex, and should be directed by gastroenterologists, hepatologists (doctors specially trained in treating diseases of the liver), or infectious disease specialists for several reasons including:

The diagnosis of chronic viral hepatitis may not be straightforward. Sometimes a liver biopsy may have to be performed for confirmation of liver damage. Doctors experienced in managing chronic liver diseases must weigh the risk of liver biopsy against the potential benefits of the biopsy.
Not all patients with chronic viral hepatitis are candidates for treatment. Some patients need no treatment (since some patients with chronic hepatitis B and C do not develop progressive liver damage or liver cancer).
Medications for chronic infection with hepatitis B and hepatitis C are not always effective. Prolonged treatment (6 months to years) often is necessary. Even with prolonged treatment, rates of successful treatment (defined as complete and lasting eradication of the virus) often are low (usually less than 80% and often around 50%).
Most of the medications such as interferon and ribavirin can have serious side effects, and doses may have to be reduced.
There are several different strains of hepatitis C viruses with differing susceptibilities to medications. For example, hepatitis C type 3 is more likely to respond to interferon injections and ribavirin than type 1. Certain hepatitis B strains are resistant to lamivudine but respond to adefovir or entecavir.
In addition, recent research has shown that combination of certain antiviral medications result in a cure (viral clearance) in many patients with chronic hepatitis C. Further studies and FDA approval is pending.

Fulminant hepatitis

Treatment of acute fulminant hepatitis should be done in centers that can perform liver transplantation since acute fulminant hepatitis has a high mortality (about 80%) without liver transplantation

How is viral hepatitis prevented?

Prevention of hepatitis involves measures to avoid exposure to the viruses, using immunoglobulin in the event of exposure, and vaccines. Administration of immunoglobulin is called passive protection because antibodies from patients who have had viral hepatitis are given to the patient. Vaccination is called active protection because killed viruses or non-infectious components of viruses are given to stimulate the body to produce its own antibodies.

Avoidance of exposure to viruses

Prevention of viral hepatitis, like any other illness, is preferable to reliance upon treatment. Taking precautions to prevent exposure to another individual's blood (exposure to dirty needles), semen (unprotected sex), and other bodily secretions and waste (stool, vomit) will help prevent the spread of all of these viruses.

Use of immunoglobulins

Immune serum globulin (ISG) is human serum that contains antibodies to hepatitis A. ISG can be administered to prevent

the duration of protection is several months. ISG usually is given to travelers to regions of the world where there are high rates of hepatitis A infection and to close or household contacts of patients with hepatitis A infection. ISG is safe with few side effects.

Hepatitis B immune globulin or HBIG (BayHep B), is human serum that contains antibodies to hepatitis B. HBIG is made from plasma (a blood product) that is known to contain a high concentration of antibodies to the hepatitis B surface antigen. If given within 10 days of exposure to the virus, HBIG almost always is successful in preventing infection. Even if given a bit later, however, HBIG may lessen the severity of HBV infection. The protection against hepatitis B lasts for about three weeks after the HBIG is given. HBIG also is given at birth to infants born to mothers known to have hepatitis B infection. In addition, HBIG is given to individuals exposed to HBV because of sexual contact or to healthcare workers accidentally stuck by a needle known to be contaminated with blood from an infected person

Hepatitis Vaccinations

 Share Your Story
Hepatitis A

Two hepatitis A vaccines are available in the US, hepatitis A vaccine (Havrix, Vaqta). Both contain inactive (killed) hepatitis A virus. For adults, two doses of the vaccine are recommended. After the first dose, protective antibodies develop in 70% of vaccine recipients within 2 weeks, and almost 100% of recipients by 4 weeks. After two doses of the hepatitis A vaccine, immunity against hepatitis A infection is believed to last for many years.

Individuals at increased risk for acquiring hepatitis A and individuals with chronic liver disease (for example, cirrhosis or chronic hepatitis C) should be vaccinated. Although individuals with chronic liver disease are not at increased risk for acquiring hepatitis A, they can develop serious (sometimes fatal) liver failure if they become infected with hepatitis A and, thus, they should be vaccinated.

Individuals at increased risk of acquiring hepatitis A are:

Travelers to countries where hepatitis A is common
Men who have sex with men
Illegal drug users (either injection or non-injection drug use)
Researchers working with hepatitis A or with primates that are susceptible to infection with hepatitis A
Patients with clotting factor disorders who are receiving clotting factor concentrates that can transmit hepatitis A
Some local health authorities or private companies may require hepatitis A vaccination for food handlers.

Because protective antibodies take weeks to develop, travelers to countries where infection with hepatitis A is common should be vaccinated at least 4 weeks before departure. The Centers for Disease Control (CDC) recommends that immunoglobulin be given in addition to vaccination if departure is prior to 4 weeks. Immunoglobulin provides quicker protection than the vaccines, but the protection is short-lived.

Hepatitis B

For active vaccination, a harmless hepatitis B antigen is given to stimulate the body's immune system to produce protective antibodies against the surface antigen of hepatitis B. Vaccines that are currently available in the U.S. are made (synthesized) using recombinant DNA technology (joining DNA segments). These recombinant hepatitis B vaccines, hepatitis B vaccine (Energix-B and Recombivax-HB) are constructed to contain only that part of the surface antigen that is very potent in stimulating the immune system to produce antibodies. The vaccine contains no viral component other than the surface antigen, and therefore, cannot cause HBV infections. Hepatitis B vaccines should be given in three doses with the second dose 1 to 2 months after the first dose, and the third dose 4 to 6 months after the first dose. For the best results, the vaccinations should be given in the deltoid (shoulder) muscles and not in the buttocks.

Hepatitis B vaccines are 95% effective in healthy adults. Five percent of vaccinated individuals will fail to develop the necessary antibodies for immunity after the three doses. Patients with weakened immunity (such as HIV infection), older patients, and patients undergoing kidney hemodialysis are more likely to fail to respond to the vaccines.

Hepatitis B vaccine is recommended for:

All infants
Adolescents under 18 years of age who did not receive hepatitis B vaccine as infants
People occupationally exposed to blood or body fluids
Residents and staff of institutions for the developmentally disabled
Patients receiving kidney hemodialysis
People who with hemophilia and other patients receiving clotting factor concentrates
Household contacts and sexual partners of patients infected with hepatitis B chronically
Travelers who will spend more than 6 months in regions with high rates of hepatitis B infection
Injection drug users and their sexual partners
Men who have sex with men, men or women with multiple sex partners, or recent infection with a sexually transmitted infection
Inmates of long-term correctional facilities
All pregnant women should have a blood test for the antibody to hepatitis B virus surface antigen. Women who test positive for hepatitis B virus (positive hepatitis B surface antigen) risk transmitting the virus to their infants during labor, and, therefore, infants born to mothers with hepatitis B infection should receive HBIG in addition to hepatitis B vaccine at birth. The reason for giving both immunoglobulin and vaccine is that even though hepatitis B vaccine can offer long lasting, active immunity, immunity takes weeks or months to develop. Until active immunity develops, the short-lived, passive antibodies from the HBIG protect the infant.

Unvaccinated individuals exposed to materials infected with hepatitis B (such as healthcare workers stuck by a contaminated needle) will need HBIG in addition to hepatitis B vaccine for the same reason as infants born to mothers with hepatitis B infection.

Hepatitis C and D

There is currently no vaccine for hepatitis C. Development of such a vaccine is difficult due to the six different forms (genotypes) of hepatitis C. No vaccine for hepatitis D is available. However, HBV vaccine can prevent an individual not infected with HBV from contracting hepatitis D because hepatitis D virus requires live HBV to replicate in the body.

What is the prognosis of viral hepatitis?

The prognosis of viral hepatitis for most patients is good; however, this prognosis varies somewhat depending on the infecting virus. For example, those patients who develop chronic hepatitis have a worse prognosis because of the potential to develop cirrhosis, liver failure, liver cancer (hepatocellular carcinoma), and occasionally death. Symptoms of viral hepatitis such as fatigue, poor appetite, nausea, and jaundice usually subside in several weeks to months, without any specific treatment. In fact, virtually all patients with acute infection with HAV and most adults (greater than 95%) with acute HBV recover completely. Complete recovery from viral hepatitis means that:

the hepatitis virus has been completely eliminated from the liver by the body's immune system,
the inflammation in the liver subsides,
the patient develops immunity to future infection with the same virus, and
the patient cannot transmit the infection to others.

Unfortunately, not all patients with viral hepatitis recover completely. Five percent of patients with acute HBV infection and about 60% of patients with acute HCV infection develop chronic hepatitis. Patients (about 0.5% to 1%) that develop fulminant hepatitis have about an 80% fatality rate. Chronic HCV infections are the leading cause for liver transplants.

Because the liver works to detoxify substances, this task is compromised during acute and chronic viral hepatitis infections. Consequently, avoiding items that may stress the compromised livers function (for example, alcohol, smoking, taking drugs that require liver processing) should be strongly considered by the patient to improve their prognosis.

Hepatitis (Viral Hepatitis, A, B, C, D, E, G)